It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
High myopia can lead to pathologic myopia and visual impairment, whereas its causes are unclear. We retrospectively researched high myopia cases from patient records to investigate the association between axial elongation and myopic maculopathy. Sixty-four eyes were examined in patients who visited the department between July 2017 and June 2018, had an axial length of 26 mm or more, underwent fundus photography, and had their axial length measured twice or more. The average axial length was 28.29 ± 1.69 mm (mean ± standard deviation). The average age was 58.3 ± 14.4 years old. Myopic maculopathy was categorized as mild (grades 0 and 1) and severe (grades 2, 3, and 4). The severe group had longer axial lengths than the mild group (P < 0.05). Moreover, the severe group exhibited thinner choroidal thickness than the mild group (P < 0.05). When subjects were grouped by axial elongation over median value within a year, the elongation group showed thinner central choroidal thickness than the non-elongation group (142.1 ± 91.9 vs. 82.9 ± 69.8, P < 0.05). In conclusion, in patients with high myopia, the severity of maculopathy correlated with choroidal thickness and axial length. Thinner choroidal thickness was associated with axial elongation based on the baseline axial length.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Keio University School of Medicine, Department of Ophthalmology, Shinjuku-ku, Japan (GRID:grid.26091.3c) (ISNI:0000 0004 1936 9959)
2 Keio University School of Medicine, Department of Ophthalmology, Shinjuku-ku, Japan (GRID:grid.26091.3c) (ISNI:0000 0004 1936 9959); Keio University School of Medicine, Laboratory of Photobiology, Shinjuku-ku, Japan (GRID:grid.26091.3c) (ISNI:0000 0004 1936 9959)
3 Keio University School of Medicine, Department of Ophthalmology, Shinjuku-ku, Japan (GRID:grid.26091.3c) (ISNI:0000 0004 1936 9959); Keio University School of Medicine, Laboratory of Photobiology, Shinjuku-ku, Japan (GRID:grid.26091.3c) (ISNI:0000 0004 1936 9959); Keio University School of Medicine, Chorioretinal Biology, Shinjuku-ku, Japan (GRID:grid.26091.3c) (ISNI:0000 0004 1936 9959)
4 Keio University School of Medicine, Laboratory of Photobiology, Shinjuku-ku, Japan (GRID:grid.26091.3c) (ISNI:0000 0004 1936 9959)
5 Keio University School of Medicine, Department of Ophthalmology, Shinjuku-ku, Japan (GRID:grid.26091.3c) (ISNI:0000 0004 1936 9959); Tsubota Laboratory, Inc., Shinjuku-ku, Japan (GRID:grid.26091.3c) (ISNI:0000 0004 1936 9959)